The purpose of this study is to evaluate the effects of the probiotic Lactobacillus plantarum 3547 over different inflammation and immune system markers on a healthy middle-aged group.
In this randomized double blind controlled trial, a group of healthy middle-aged people (45 to 65 years old) had a nutritional intervention to evaluate the Lactobacillus plantarum 3547 probiotic effects over different inflammation and immune system markers, the experimental group took the experimental supplement (Lactobacillus plantarum 3547) during one period of parallel study (12 weeks), the volunteers consumed 1 capsule/daily with Lactobacillus plantarum 3547 (10x109 cfu/d) immediately after finishing their meal, the capsule contains: 77 mg probiotic Lp3547 and 390 mg maltodextrins. The control group took the control supplement (Maltodextrin) during one period of parallel study (12 weeks), volunteers consumed 1 daily capsule of maltodextrin without Lactobacillus plantarum 3547 (Placebo) immediately after finishing their meal. (The capsule contains 425 mg of maltodextrin)
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
84
During one period of parallel study (12 weeks) volunteers consumed 1 capsule/daily with Lactobacillus plantarum 3547 immediately after finishing their meal.
During one period of parallel study (12 weeks), volunteers will consume 1 daily capsule of maltodextrin immediately after finishing their meal.
La Paz University Hospital
Madrid, Madrid, Spain
Change from baseline interleukin 6 (IL-6)
Time frame: 0 and 12 weeks
Change from baseline interleukin 1β (IL1β)
Time frame: 0 and 12 weeks
Change from baseline interleukin 10 (IL10)
Time frame: 0 and 12 weeks
Change from baseline cytokine Tumor necrosis factor (TNFα)
Time frame: 0 and 12 weeks
Change from baseline Mcp1 (Monocyte Chemoattractant Protein-1)
Time frame: 0 and 12 weeks
Transforming growth factor beta 1 (TGF-β1)
Time frame: 0 and 12 weeks
Change from baseline Interferon gamma (INF-γ)
Time frame: 0 and 12 weeks
Change from baseline cluster of differentiation 4 "CD4+T cells"
Time frame: 0 and 12 weeks
Change from baseline T lymphocytes
Time frame: 0 and 12 weeks
Change from baseline cluster of differentiation 8 "CD8+ T cells"
Time frame: 0 and 12 weeks
Change from baseline natural killer cells
Time frame: 0 and 12 weeks
Change from baseline B lymphocytes
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: 0 and 12 weeks